Molecular dissection of the leukemia-associated transcription factor, AML1/RUNX1,in hematopoietic regulation
Molecular dissection of the leukemia-associated transcription factor, AML1/RUNX1,in hematopoietic regulation
批准号:
14570990
负责人:
OKUDA Tsukasa
金额:
$2.62万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
急性髓系白血病1(AML1;又称Runt相关转录因子1:RUNX1)是一种转录因子,在明确的造血早期发育中起关键作用,也是白血病相关基因异常的最常见靶点。在这项研究中,我们通过胚胎干细胞和整个小鼠水平的造血挽救试验,检测了它的功能以及正常和白血病的造血。我们的发现概括如下:1.AML1的转录抑制功能是通过其C端的VWRPY基序介导的,在整个小鼠的早期造血发育中并不是必不可少的。2.纯合子携带缺失VWRPY基序的敲入的AML1等位基因的基因组修饰小鼠品系显示,遗传保守的VWRPY基序在胸腺的早期发育和CD4表达中起重要作用。3.通过对170例白血病或相关疾病的筛查,我们在外显子3到6中发现了5个(2.9%)新的突变,与矮小结构域相对应。除1例沉默突变外,其余4例均为功能缺失型等位基因:其中2例为N-末端附近移码突变,另外2例为插入突变,位于矮小结构域C-末端附近,经实验证实为非功能性突变。这些数据进一步强调,AML1的一个等位基因丢失是人类白血病发生的早期事件。
英文摘要
Acute Myeloid Leukemia 1 (AML1; also called as Runt-Related Transcription Factor 1: RUNX1) encodes a transcription factor which plays a pivotal role in early development of definitive hematopoiesis, and is the most frequent target of the leukemia-associated gene aberration. In this study, we examined its function along with normal and leukemic hematopoiesis by means of hematopoietic rescue assay at embryonic stem cell and entire mouse levels. What we found are summarized as follows:1.Transcription-repressive function of AML1,which is mediated through its C-terminal VWRPY-motif, is not essential for the early hematopoietic development in the context of the entire mouse.2.Genome-modified mouse lines which homozygously harbor knocked-in AML1 allele lacking of VWRPY-motif revealed that the genetically conserved VWRPY-motif plays an important role in early development of thymus and CD4-expression.3.By screening 170 cases of leukemia or related disorders, we found five (2.9%) novel mutations within the exons 3 through 6,which correspond to the runt domain. Apart from a case with a silent mutation, the remaining four cases were all loss-of-function type of the allele : Two of them were frame-shift near the N-terminus, and the other two, I150ins and K168,were insertion mutations near the C-terminal end of the runt domain which were experimentally proven to be non-functional. These data further underscore the notice that one-allele loss of AML1 serves as an early event of human leukemogenesis.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Nishimura, M.: "VWRPY motifdependent and -independent roles of AML1IRunx1 transcription factor in murine hematopoietic development."Blood. 103. 562-570 (2004)
Nishimura, M.:“AML1IRunx1 转录因子在小鼠造血发育中的 VWRPY 基序依赖性和非依赖性作用。”血液。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nishimura M, Fukushima-Nakase Y, Fujita Y, Nakao M, Toda S, Kitamura N, Abe T, Okuda T.: "VWRPY motif-dependent and -independent roles of AML1/Runx1 transcription factor in murine hematopoictic development."Blood. 103(2). 562-570 (2004)
Nishimura M、Fukushima-Nakase Y、Fujita Y、Nakao M、Toda S、Kitamura N、Abe T、Okuda T.:“AML1/Runx1 转录因子在小鼠造血发育中的 VWRPY 基序依赖和独立作用。”血液。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
奥田 司: "AML1と造血発生"分子細胞治療. 1・2. 149-159 (2002)
奥田司:“AML1和造血发育”《分子细胞疗法》1・2(2002年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nishimura, M.: "VWRPY motif-dependent and -independent roles of AML1/Runx1 transcription factor in murine hematopoietic development."Blood. 103・2. 562-570 (2004)
Nishimura, M.:“AML1/Runx1 转录因子在小鼠造血发育中的 VWRPY 基序依赖性和非依赖性作用。”Blood 103・2。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakao, M.: "Novel loss-of-function mutations of the haematopoiesis-related transcription factor, AML1/RUNX1,detected in acute myeloblastic leukaemia and myelodysplastic syndrome"British Journal of Haematology. (印刷中). (2004)
Nakao, M.:“在急性成髓细胞白血病和骨髓增生异常综合征中检测到的造血相关转录因子 AML1/RUNX1 的新型功能丧失突变”英国血液学杂志(2004 年出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 7 条
RUNX1 as a molecular target for a novel hematopoietic reguation
-
批准号:15K09487
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2015
-
负责人:OKUDA Tsukasa
-
依托单位:
Transcriptional Dysregulation in Abnormal Hematopoiesis and Leukemia
-
批准号:21591214
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:OKUDA Tsukasa
-
依托单位:
Leukemogenic Mechanism by genomic mutations of hematopoietic-speci is transcription factor, AML1/RUNX1
-
批准号:18591078
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.57万
-
财政年份:2006
-
负责人:OKUDA Tsukasa
-
依托单位:
Molecular basis for leukemic transformation caused by chimeric protein involving the transcription factor AML1 (PEBP2aB).
-
批准号:12671000
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2000
-
负责人:OKUDA Tsukasa
-
依托单位:
Biologic characterization of leukemia-associated transcription factor AML1 (PEBP2αB) in hematopoiesis
-
批准号:11138251
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas (A)
-
资助金额:$4.8万
-
财政年份:1999
-
负责人:OKUDA Tsukasa
-
依托单位:
Molecular mechanism of hematopoietic regulation by leukemia-related transcription factor AML1(PEBP2αB)
-
批准号:10670961
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:1998
-
负责人:OKUDA Tsukasa
-
依托单位:
国内基金
海外基金
登录
查看更多内容
空气颗粒物通过调控白血病抑制因子参与影响IgA肾病进展的作用与机制研究
-
批准号:82370711
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:谢静远
-
依托单位:
ELL在前列腺癌发生中的负性作用机制及其临床意义
-
批准号:81101948
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:刘凌琪
-
依托单位:
PBX蛋白促肿瘤转移及VCP表达的调节作用研究
-
批准号:30801382
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2008
-
负责人:裘莹
-
依托单位:
肿瘤DNA低甲基化发生分子机理及其对白血病发病重要性的研究
-
批准号:30872933
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2008
-
负责人:张权庚
-
依托单位:
一个新型抗癌化合物对急性骨髓性白血病细胞Sin3A复合体的作用
-
批准号:30672422
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:张玉祥
-
依托单位:
人白血病干细胞与耐药性的关系研究
-
批准号:30572203
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2005
-
负责人:齐静
-
依托单位: